vers la météo de la validation par utilisateur

Ingenuity261

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 15 - PMID ?

In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      +-------COMP:N-N(from)-------+-------------------------APPOS-------------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      |           +--MOD_ATT:N-ADJ-+        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           |      +MOD_ATT:N+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__NODE__)
MOD_ATT:N-ADJ (__NODE__,female)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,period)
OBJ:V-N (with,mcg/g/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 1 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+                                                   
      |      +----------------------------------------APPOS---------------------------------------+                   |          +------------COMP:N-N(of)------------+   
      |      +-------COMP:N-N(from)-------+                                                       |                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      |           +--MOD_ATT:N-ADJ-+        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           |      +MOD_ATT:N+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__NODE__)
APPOS (toilet,period)
MOD_ATT:N-ADJ (__NODE__,female)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (with,mcg/g/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 2 
             +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                   
             |                  +------------------------------------COMP:V-N(from)-----------------------------------+                                                   
             |                  |         +----------------------------------SUBJ:V-N---------------------------------+          +------------COMP:N-N(of)------------+   
             |                  |         +-------------------------APPOS-------------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
             |                  |         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      +MOD_AT+           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
MOD_ATT:N-N (toilet,liver)
MOD_ATT:N-N (__SP__,female)
APPOS (__NODE__,period)
OBJ:V-N (with,mcg/g/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,toilet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 3 
             +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                   
             |                  +------------------------------------COMP:V-N(from)-----------------------------------+                                                   
             |                  |         +----------------------------------SUBJ:V-N---------------------------------+          +------------COMP:N-N(of)------------+   
             |                  |         +-------------------------APPOS-------------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
             |                  |         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      +MOD_AT+           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
MOD_ATT:N-N (toilet,liver)
MOD_ATT:N-ADJ (__SP__,female)
APPOS (__NODE__,period)
OBJ:V-N (with,mcg/g/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,toilet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 4 
             +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                   
             |                            +----------------------------------SUBJ:V-N---------------------------------+          +------------COMP:N-N(of)------------+   
             |                            +-------------------------APPOS-------------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
             +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      +MOD_AT+           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
MOD_ATT:N-N (toilet,liver)
COMP:N-N(from) (toilet,__SP__)
MOD_ATT:N-N (__SP__,female)
APPOS (__NODE__,period)
OBJ:V-N (with,mcg/g/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,toilet)
SUBJ:V-N (decrease,__NODE__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 5 
             +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                   
             |                            +----------------------------------SUBJ:V-N---------------------------------+          +------------COMP:N-N(of)------------+   
             |                            +-------------------------APPOS-------------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
             +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      +MOD_AT+           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
MOD_ATT:N-N (toilet,liver)
COMP:N-N(from) (toilet,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
APPOS (__NODE__,period)
OBJ:V-N (with,mcg/g/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,toilet)
SUBJ:V-N (decrease,__NODE__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 6 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      |                            +-------------------------APPOS-------------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           +MOD_AT+--APPOS--+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__SP__)
MOD_ATT:N-N (__SP__,female)
APPOS (__SP__,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mcg/g/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 7 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      |                            +-------------------------APPOS-------------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           +MOD_AT+--APPOS--+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
APPOS (__SP__,__NODE__)
APPOS (__NODE__,period)
OBJ:V-N (with,mcg/g/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 8 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      +------------APPOS-----------+-------------------------APPOS-------------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__SP__)
APPOS (toilet,__NODE__)
MOD_ATT:N-N (__SP__,female)
APPOS (__NODE__,period)
OBJ:V-N (with,mcg/g/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 9 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      +------------APPOS-----------+-------------------------APPOS-------------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__SP__)
APPOS (toilet,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
APPOS (__NODE__,period)
OBJ:V-N (with,mcg/g/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 10 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+                                                   
      |      |                                     +--------------------OBJ:V-N-------------------+                   |          +------------COMP:N-N(of)------------+   
      |      +-------COMP:N-N(from)-------+        |                     +------------COMP:N-N(of)-----------+        |          |           +------MOD_ATT:N-ADJ-----+   
      |      |           +--MOD_ATT:N-ADJ-+        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           |      +MOD_ATT:N+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__NODE__)
MOD_ATT:N-ADJ (__NODE__,female)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/g/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 11 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+                                                   
      |      |                                     +--------------------OBJ:V-N-------------------+                   |          +------------COMP:N-N(of)------------+   
      |      +-------COMP:N-N(from)-------+        |                     +------------COMP:N-N(of)-----------+        |          |           +------MOD_ATT:N-ADJ-----+   
      |      |           +--MOD_ATT:N-ADJ-+        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           |      +MOD_ATT:N+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__NODE__)
MOD_ATT:N-ADJ (__NODE__,female)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/g/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 12 
             +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                   
             |                  +------------------------------------COMP:V-N(from)-----------------------------------+                                                   
             |                  |         +----------------------------------SUBJ:V-N---------------------------------+                                                   
             |                  |         |        +--------------------OBJ:V-N-------------------+                   |          +------------COMP:N-N(of)------------+   
             |                  |         |        |                     +------------COMP:N-N(of)-----------+        |          |           +------MOD_ATT:N-ADJ-----+   
             |                  |         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      +MOD_AT+           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
MOD_ATT:N-N (toilet,liver)
MOD_ATT:N-N (__SP__,female)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/g/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,toilet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 13 
             +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                   
             |                  +------------------------------------COMP:V-N(from)-----------------------------------+                                                   
             |                  |         +----------------------------------SUBJ:V-N---------------------------------+                                                   
             |                  |         |        +--------------------OBJ:V-N-------------------+                   |          +------------COMP:N-N(of)------------+   
             |                  |         |        |                     +------------COMP:N-N(of)-----------+        |          |           +------MOD_ATT:N-ADJ-----+   
             |                  |         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      +MOD_AT+           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
MOD_ATT:N-N (toilet,liver)
MOD_ATT:N-ADJ (__SP__,female)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/g/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,toilet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 14 
             +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                   
             |                            +----------------------------------SUBJ:V-N---------------------------------+                                                   
             |                            |        +--------------------OBJ:V-N-------------------+                   |          +------------COMP:N-N(of)------------+   
             |                            |        |                     +------------COMP:N-N(of)-----------+        |          |           +------MOD_ATT:N-ADJ-----+   
             +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      +MOD_AT+           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
MOD_ATT:N-N (toilet,liver)
COMP:N-N(from) (toilet,__SP__)
MOD_ATT:N-N (__SP__,female)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/g/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,toilet)
SUBJ:V-N (decrease,__NODE__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 15 
             +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                   
             |                            +----------------------------------SUBJ:V-N---------------------------------+                                                   
             |                            |        +--------------------OBJ:V-N-------------------+                   |          +------------COMP:N-N(of)------------+   
             |                            |        |                     +------------COMP:N-N(of)-----------+        |          |           +------MOD_ATT:N-ADJ-----+   
             +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      +MOD_AT+           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
MOD_ATT:N-N (toilet,liver)
COMP:N-N(from) (toilet,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/g/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,toilet)
SUBJ:V-N (decrease,__NODE__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 16 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+                                                   
      |      |                                     +--------------------OBJ:V-N-------------------+                   |          +------------COMP:N-N(of)------------+   
      |      |                                     |                     +------------COMP:N-N(of)-----------+        |          |           +------MOD_ATT:N-ADJ-----+   
      |      +--COMP:N-N(from)--+                  +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           +MOD_AT+--APPOS--+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__SP__)
MOD_ATT:N-N (__SP__,female)
APPOS (__SP__,__NODE__)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/g/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 17 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+                                                   
      |      |                                     +--------------------OBJ:V-N-------------------+                   |          +------------COMP:N-N(of)------------+   
      |      |                                     |                     +------------COMP:N-N(of)-----------+        |          |           +------MOD_ATT:N-ADJ-----+   
      |      +--COMP:N-N(from)--+                  +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           +MOD_AT+--APPOS--+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
APPOS (__SP__,__NODE__)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/g/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 18 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+                                                   
      |      |                                     +--------------------OBJ:V-N-------------------+                   |          +------------COMP:N-N(of)------------+   
      |      +------------APPOS-----------+        |                     +------------COMP:N-N(of)-----------+        |          |           +------MOD_ATT:N-ADJ-----+   
      |      +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__SP__)
APPOS (toilet,__NODE__)
MOD_ATT:N-N (__SP__,female)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/g/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 19 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+                                                   
      |      |                                     +--------------------OBJ:V-N-------------------+                   |          +------------COMP:N-N(of)------------+   
      |      +------------APPOS-----------+        |                     +------------COMP:N-N(of)-----------+        |          |           +------MOD_ATT:N-ADJ-----+   
      |      +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__SP__)
APPOS (toilet,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/g/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 20 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      +-------COMP:N-N(from)-------+        +--------------------OBJ:V-N-------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      |           +--MOD_ATT:N-ADJ-+        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           |      +MOD_ATT:N+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__NODE__)
MOD_ATT:N-ADJ (__NODE__,female)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 21 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      +-------COMP:N-N(from)-------+        +--------------------OBJ:V-N-------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      |           +--MOD_ATT:N-ADJ-+        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           |      +MOD_ATT:N+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__NODE__)
MOD_ATT:N-ADJ (__NODE__,female)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 22 
             +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                   
             |                  +------------------------------------COMP:V-N(from)-----------------------------------+                                                   
             |                  |         +----------------------------------SUBJ:V-N---------------------------------+          +------------COMP:N-N(of)------------+   
             |                  |         |        +--------------------OBJ:V-N-------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
             |                  |         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      +MOD_AT+           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
MOD_ATT:N-N (toilet,liver)
MOD_ATT:N-N (__SP__,female)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,toilet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 23 
             +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                   
             |                  +------------------------------------COMP:V-N(from)-----------------------------------+                                                   
             |                  |         +----------------------------------SUBJ:V-N---------------------------------+          +------------COMP:N-N(of)------------+   
             |                  |         |        +--------------------OBJ:V-N-------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
             |                  |         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      +MOD_AT+           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
MOD_ATT:N-N (toilet,liver)
MOD_ATT:N-ADJ (__SP__,female)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,toilet)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,__NODE__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 24 
             +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                   
             |                            +----------------------------------SUBJ:V-N---------------------------------+          +------------COMP:N-N(of)------------+   
             |                            |        +--------------------OBJ:V-N-------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
             +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      +MOD_AT+           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
MOD_ATT:N-N (toilet,liver)
COMP:N-N(from) (toilet,__SP__)
MOD_ATT:N-N (__SP__,female)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,toilet)
SUBJ:V-N (decrease,__NODE__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 25 
             +----------------------------------------------COMP:V-N(In)----------------------------------------------+                                                   
             |                            +----------------------------------SUBJ:V-N---------------------------------+          +------------COMP:N-N(of)------------+   
             |                            |        +--------------------OBJ:V-N-------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
             +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      +MOD_AT+           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
MOD_ATT:N-N (toilet,liver)
COMP:N-N(from) (toilet,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,toilet)
SUBJ:V-N (decrease,__NODE__)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 26 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      |                                     +--------------------OBJ:V-N-------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      +--COMP:N-N(from)--+                  +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           +MOD_AT+--APPOS--+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__SP__)
MOD_ATT:N-N (__SP__,female)
APPOS (__SP__,__NODE__)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 27 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      |                                     +--------------------OBJ:V-N-------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      +--COMP:N-N(from)--+                  +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           +MOD_AT+--APPOS--+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__SP__)
MOD_ATT:N-ADJ (__SP__,female)
APPOS (__SP__,__NODE__)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 28 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      +------------APPOS-----------+        +--------------------OBJ:V-N-------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__SP__)
APPOS (toilet,__NODE__)
MOD_ATT:N-N (__SP__,female)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 29 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      +------------APPOS-----------+        +--------------------OBJ:V-N-------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      +--COMP:N-N(from)--+         |        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           +MOD_AT+         |        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__SP__)
APPOS (toilet,__NODE__)
MOD_ATT:N-ADJ (__SP__,female)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 30 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      +-------COMP:N-N(from)-------+-------------------------APPOS-------------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      |           +---MOD_ATT:N-N--+        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           |      +MOD_ATT:N+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__NODE__)
MOD_ATT:N-N (__NODE__,female)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (__NODE__,period)
OBJ:V-N (with,mcg/g/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 31 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+                                                   
      |      +----------------------------------------APPOS---------------------------------------+                   |          +------------COMP:N-N(of)------------+   
      |      +-------COMP:N-N(from)-------+                                                       |                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      |           +---MOD_ATT:N-N--+        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           |      +MOD_ATT:N+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__NODE__)
APPOS (toilet,period)
MOD_ATT:N-N (__NODE__,female)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (with,mcg/g/day)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 32 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+                                                   
      |      |                                     +--------------------OBJ:V-N-------------------+                   |          +------------COMP:N-N(of)------------+   
      |      +-------COMP:N-N(from)-------+        |                     +------------COMP:N-N(of)-----------+        |          |           +------MOD_ATT:N-ADJ-----+   
      |      |           +---MOD_ATT:N-N--+        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           |      +MOD_ATT:N+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__NODE__)
MOD_ATT:N-N (__NODE__,female)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/g/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 33 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+                                                   
      |      |                                     +--------------------OBJ:V-N-------------------+                   |          +------------COMP:N-N(of)------------+   
      |      +-------COMP:N-N(from)-------+        |                     +------------COMP:N-N(of)-----------+        |          |           +------MOD_ATT:N-ADJ-----+   
      |      |           +---MOD_ATT:N-N--+        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           |      +MOD_ATT:N+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__NODE__)
MOD_ATT:N-N (__NODE__,female)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/g/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 34 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      +-------COMP:N-N(from)-------+        +--------------------OBJ:V-N-------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      |           +---MOD_ATT:N-N--+        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           |      +MOD_ATT:N+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__NODE__)
MOD_ATT:N-N (__NODE__,female)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])
Analyse 35 
      +--------------------------------------------------COMP:V-N(In)-------------------------------------------------+                                                   
      |      +------------------------------------------------SUBJ:V-N------------------------------------------------+          +------------COMP:N-N(of)------------+   
      |      +-------COMP:N-N(from)-------+        +--------------------OBJ:V-N-------------------+                   |          |           +------MOD_ATT:N-ADJ-----+   
      |      |           +---MOD_ATT:N-N--+        +-------OBJ:V-N-------+                        +COMP:N-N(o+        |          |           |         +--MOD_ATT:N-N-+   
      |      |           |      +MOD_ATT:N+        |       +COMP:N-+     |               +MOD_ATT:+      +MOD+        +--OBJ:V-N-+           |         |      +MOD_ATT+   
      |      |           |      |         |        |       |       |     |               |        |      |   |        |          |           |         |      |       |   
 In liver tissue from female __SP__ , __NODE__ ( with a dosage of 20 mcg/g/day and a treatment period of 6 days ) decreases expression of __SP__ SREBP 1 [__NODE__] mRNA .
COMP:N-N(from) (toilet,__NODE__)
MOD_ATT:N-N (__NODE__,female)
MOD_ATT:N-ADJ (__NODE__,__SP__)
OBJ:V-N (with,mcg/g/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,6)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,toilet)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-N (mRNA,1)
MOD_ATT:N-N (mRNA,[__NODE__])